A new scoring system for peritoneal metastasis in gastric cancer

Size: px
Start display at page:

Download "A new scoring system for peritoneal metastasis in gastric cancer"

Transcription

1 Gastric Cancer (2003) 6: DOI /s by International and Japanese Gastric Cancer Associations Original article A new scoring system for peritoneal metastasis in gastric cancer Takashi Fujimura, Kaname Ishii, Katsunobu Oyama, Tomoharu Miyashita, Shinichi Kinami, Itasu Ninomiya, Hirohisa Kitagawa, Sachio Fushida, Genichi Nishimura, Masato Kayahara, Koichi Shimizu, Tetsuo Ohta, and Koichi Miwa Gastroenterologic Surgery, Division of Cancer Medicine, Graduate School of Medical Science, Kanazawa University, 13-1 Takaramachi, Kanazawa , Japan Abstract Background. The degree of peritoneal metastasis (PM) of gastric cancer has been classified into four grades (P0, P1, P2, and P3) in the Japanese Classification of Gastric Carcinoma, First English Edition. However, the PM category in this version was so ambiguous in terms of volumetry that it was unlikely to estimate PM status correctly. We have developed a new volume scoring system for PM, modifying Sugarbaker s classification. Methods. Eighty-five patients with gastric cancer with PM underwent surgery and/or laparoscopy at our hospital at Kanazawa University between January 1990 and December The grading (Gr) by the volume scoring system was decided according to the sum of scores for nine (in male) or ten (in female) abdominopelvic regions. These regions included left subphrenics, right subphrenics, left flank, right flank, pelvis, omenta, mesentery, small and large bowels, ovaries (only for females), and other intraabdominal organs. Volumetry for each region was carried out using the following categories: VS0, indicating the absence of cancer in a particular abdominopelvic region; VS1, indicating that tumor nodules are less than 10mm in diameter; VS2, indicating tumors between 1 and 5cm in diameter; and VS3, indicating that tumor is more than 5cm in diameter or that an organ is coated by a mat of tumor (confluent disease). The scores for VS0, VS1, VS2, and VS3 were 0, 1, 2, and 3 points, respectively. Total scores of 1 to 3 were the equivalent of Gr I, total scores of 4 to 6 were equivalent to Gr II, total scores of 7 to 9 were equivalent to Gr III, and total scores of more than 9 were equivalent to Gr IV. Results. There was no significant difference between P1 and P2, or between P1 and P3 in survival curves. But the 50% survival times of Gr I, Gr II, Gr III, and Gr IV were 1.23, 0.66, 0.67, and 0.32 years, respectively. The prognosis of Gr I was significantly better than that of any other grades. Eight of the 28 patients (29%) assessed as Gr I survived more than 2 years, whereas only 2 of the 57 (4%) assessed as Gr II, Gr III, or Gr IV did so. Multivariate analysis by Cox s proportional hazard model revealed that the volume scoring, resection of primary Offprint requests to: T. Fujimura Received: February 26, 2003 / Accepted: May 12, 2003 tumor, and resection of peritoneal tumor were independent factors to predict prognosis. Conclusion. These results showed that the volume scoring system was strongly related to the prognosis, and the patients assessed as Gr I had a great probability of cure by surgery. Key words Peritoneal metastasis of gastric cancer Volume scoring system Sugarbaker s classification Introduction The most frequent cause of death in gastric cancer is peritoneal metastasis (PM), which is difficult to diagnose preoperatively (in spite of the development of diagnostic imaging) and difficult to cure completely with surgery or chemotherapy. Moreover, a therapeutic strategy has not yet been established, because there is no standardized assessment of PM suitable for statistical analysis. The degree of PM in gastric cancer was originally classified into four grades (P0, P1, P2, and P3) in the Japanese Classification of Gastric Carcinoma, First English Edition (the First Edition) [1], edited by Japanese Research Society for Gastric Cancer. This classification was changed to two categories, positive or negative PM, in the Japanese Classification of Gastric Carcinoma, Second English Edition (the Second Edition) [2], because there was no significant difference in prognosis between any two PM- positive groups (P1, P2, or P3) [3]. However, the PM category of the First Edition was so ambiguous in terms of volumetry that it was unlikely to lead to a correct estimate of PM status. For example, any major peritoneal metastasis to the peritoneum adjacent to the stomach was regarded as P1 metastasis, and only 2-mm nodules on the pelvic peritoneum were assessed as P2. The grading of PM in the Second Edition has been greatly simplified. According to this new edition, if a patient shows PM, however small the peritoneal tumor may be, the patient is catego-

2 T. Fujimura et al.: New classification for peritoneal metastasis 147 rized as stage IV, the final stage of this disease. Recently, cure-oriented surgery for stage IV gastric cancer has been abandoned by most surgeons. We fear, however, that surgeons may miss patients who have a chance of being cured or having their survival prolonged because of inadequate classification of PM in both editions: incompleteness in terms of volumetry in the First Edition and oversimplification in the Second Edition. When confronted in the operating room with PM from gastric cancer, the clinician must make a decision regarding the possible risks and benefits of aggressive treatment versus best supportive care [4]. It is therefore essential that objective criteria are established by which any clinician can decide on the optimal treatment strategy. In the present study we developed a new semiquantitative scoring system for PM by modifying Sugarbaker s classification (Jacquet and Sugarbaker [5]), and showed that the patients assessed as Gr I with our volume scoring system had a high probability of being cured by surgery. Patients and methods A total of 735 patients with histologically proven gastric carcinoma underwent surgery and/or laparoscopy at the Department of Gastroenterologic Surgery of Kanazawa University between January 1990 and December Eighty-five (11.6%) of the patients had peritoneal metastases; 50 were males and 35, females; aged from 14 to 84 years, with an average age of years. The clinical and pathological findings were based on the guidelines of the first edition of the Japanese Classification of Gastric Carcinoma (the First Edition), edited by the Japanese Research Society for Gastric Cancer. According to the First Edition, the degree of peritoneal metastasis is defined as: P0, no peritoneal metastasis; P1, metastases to the adjacent but not to the distant peritoneum; P2, a few metastases to the distant peritoneum; and P3, numerous metastases to the distant peritoneum. The adjacent peritoneum is defined as including the peritoneum of the lesser sac as well as the lesser and greater omenta. Cytoreductive surgery for the primary tumor and the peritoneal tumor was performed in 66 (78%) and 33 (39%) patients, respectively (Table 1). The resection of peritoneal tumor included picking-up resection of peritoneal nodules (n 24) and subtotal peritonectomy (n 9). Fifty-two patients (61%) underwent intraperitoneal chemotherapy using cisplatin, mitomycin C, and etoposide. We assessed the distribution and the volume of the intraperitoneal tumors. Using a modified version Jacquet and Sugarbaker s classification [5], we divided Fig. 1. Abdominopelvic anatomic regions. The peritoneal surface was divided into ten abdominopelvic regions five parietal and five visceral regions the abdominopelvic anatomic sites into ten regions for the separate assessment of peritoneal tumors (Fig. 1). The abdominopelvic regions comprise five parietal and five visceral regions on the peritoneum. The parietal regions consist of the left subphrenics, right subphrenics, left flank, right flank, and pelvis. The upper transverse plane is the lowest aspect of the costal margin and the lower transverse plane is the aspect of the anterior superior iliac spine. The visceral regions consist of the minor and major omenta, mesentery, small and large bowels, ovaries (only for females), and other intraabdominal organs. For volumetric scoring for each region, we used the following categories: VS0, absence of cancer in a particular abdominopelvic region; VS1, tumor nodules less than 10mm in diameter; VS2, tumors between 1 and 5cm in diameter; and VS3, tumors more than 5cm in diameter or an organ coated by a mat of tumors (confluent disease) (Fig. 2A,B). The scores for VS0, VS1, VS2, and VS3 were 0, 1, 2, and 3 points, respectively. Grading (Gr) based on volumetric scoring was decided according to the sum of the scores for nine (in males) or ten (in females) abdominopelvic regions. A total score of 1 to 3 was the equivalent of Gr I, a total score of 4 to 6 was equivalent Gr II, a total score of 7 to 9 was equivalent to Gr III, and a total score of more than 9 was equivalent to Gr IV. Significant differences in proportions were determined with the χ 2 test. Patient survival was calculated by the Kaplan-Meier method, and survival curves were compared by the log rank method. Multivariate analysis for prognostic values was carried out using Cox s proportional hazards regression model. Statistical significance was defined as a P value of less than 0.05.

3 148 T. Fujimura et al.: New classification for peritoneal metastasis Table 1. Patient characteristics Gr I (n 28) Gr II (n 21) Gr III (n 16) Gr IV (n 20) Total Age (years) 64 10* * Sex (M:F) 18: 10 12: 9 12 :4 8 : 12 50:35 Type Ukn T Ukn H ( ) ( ) N Ukn Resection of primary tumor ( ) ( ) ]* Resection of peritoneal tumor ( ) ( ) ]* Intraperitoneal chemotherapy ( ) ( ) * P 0.05 T, depth of tumor invasion; H, liver metastases; N, lymph node metastases; Ukn, unknown Results Our assessment resulted in categorizing 28 patients with Gr I, 21 with Gr II, 16 with Gr III, and 20 with Gr IV. The patients with Gr IV were significantly younger than those with Gr I (Table 1). The lower the grade of PM was, the more often resections of the primary tumor and the peritoneal tumor were performed. No statistically significant relationship could be established between status of the macroscopic type, depth of tumor invasion (T factor), liver metastases (H factor), lymph node metastases (N factor), or intraperitoneal chemotherapy. The classification by the First Edition (P1, P2, and P3) was compared with the grading by the volume scoring system. All the patients assessed as P1 were categorized as Gr I. Sixteen of the 30 patients assessed as P2 were categorized as Gr I, 11 as Gr II, 2 as Gr III, and 1 as Gr IV. The patients assessed as P3 comprised 1 in Gr I, 10 in Gr II, 14 in Gr III, and 19 in Gr IV. The volumetric scoring (degree) and distribution of PM are shown in Table 2. Peritoneal tumor was found on mesentery (64%), pelvis (55%), left subphrenics (39%), right subphrenics (35%), omenta (35%), right flank (34%), left flank (33%), bowels (25%), ovaries (23%), and other organs (13%) in order of frequency. VS2 (tumors between 1 and 5 cm in diameter) appeared the most frequent of VS categories at all of the abdominopelvic anatomic sites. The 50% survival times for the P1, P2, and P3 categories according to the First Edition were 1.14, 0.92, and 0.32 years, respectively (Fig. 3). There was no significant difference in survival between P1 and P2, or between P1 and P3, while the survival of the P2 patients was significantly better than that of the P3 patients (P 0.001). Survival analysis according to the volumetric scoring system showed that 50% survival times for Gr I, Gr II, Gr III, and Gr IV were 1.23, 0.66, 0.67, and 0.32 years, respectively. The prognosis in Gr I was significantly better than that in the other grades, including Gr II, III, and IV (Fig. 4). Eight of the 28 patients (29%) assessed as Gr I survived for more than 2 years, whereas only 2 of the 57 (4%) assessed as Gr II, Gr III, or Gr IV did so. Next, we examined whether resection of the primary tumor was effective for prolonging the survival of Gr I

4 T. Fujimura et al.: New classification for peritoneal metastasis 149 A B Fig. 2. A Volume scoring system for peritoneal metastasis (modification of classification by Jacquet and Sugarbaker [5]). The degree for the volume scoring was semiquantitatively assessed according to the size of the peritoneal metastasis. Degrees of VS0, VS1, VS2, and VS3 were scored as 0, 1, 2, and 3 points, respectively. Points for volume scoring were added for all regions (regions shown in Fig. 1). B Representative photographs of peritoneal metastases according to volume scoring. The volume scoring was performed during laparotomy or laparoscopy patients (Fig. 5). As expected, the survival of the patients assessed as Gr I who had undergone resection of the primary tumor was much better than that of patients who had not (P 0.01). Multivariate analysis by Cox s proportional hazards model revealed that the volume scoring (Gr II III IV/Gr I) (odds ratio, 3.18; 95% confidence interval [CI], ; P ); resection of primary tumor (odds ratio, 0.44; 95% CI, ; P 0.023); and resection of peritoneal tumor (odds ratio, 0.50; 95% CI, ; P 0.043) were independent prognostic factors (Table 3). However, the PM classification of the

5 150 T. Fujimura et al.: New classification for peritoneal metastasis Table 2. The frequency and distribution of peritoneal metastasis Volumetric scoring Site VS0 VS1 VS2 VS3 Frequency (%) Right subphrenics (35) Left subphrenics (39) Right flank (34) Left flank (33) Pelvis (55) Omenta (35) Mesentery (64) Bowels (25) Ovary a (23) Other organs (13) a Only for females Fig. 3. Survival curves determined according to the classification in the first English edition of the Japanese classification of gastric carcinoma. The 50% survival times of the P1, P2, and P3 categories were 1.14, 0.92, and 0.32 years, respectively. There was no significant difference (n.s.) in survival between P1 and P2, or between P1 and P3 Fig. 5. Survival curves of patients assessed as Gr I, according to resection of the primary tumor. Patients with metastases to liver and/or paraaortic lymph nodes were excluded from the analysis. The 1-year and 2-year survival rates of the patients who underwent resection were 76% and 47%, significantly better than the rates of 50% and 0% for the patients who did not undergo resection (log rank test, P 0.01) First Edition (P2 3 / P1) (odds ratio, 0.51; 95% CI, ; P 0.20) was not found to be a predictor of survival. Paraaortic lymph node metastasis and cytology showed marginal importance as prognostic factors. Discussion Fig. 4. Survival curves determined by the grading in the volume scoring system. The 50% survival time of Gr I was 1.23 years, while that of the other grades, including Gr II, III, and IV, was 0.54 years. The prognosis of Gr I was significantly better than that of the other grades For most malignant tumors the prognosis depends upon the size or volume of the primary tumor. It is only natural to choose these as one of the prognostic factors for survival analysis. The PM categories in the First Edition of the Japanese classification of gastric carcinoma are so ambiguous in terms of volumetry, however, that it is unlikely that the status of PM can be correctly estimated. The four degrees of PM (P0, P1, P2, and P3)

6 T. Fujimura et al.: New classification for peritoneal metastasis 151 Table 3. Multivariate analysis for prognostic factors 95% Confidence Factor Odds ratio interval P value Age Liver metastasis ( / ) Paraaortic lymph node metastasis ( / ) P (P2 plus P3 / P1) a Volume scoring (grades II, III, and IV / grade I) Cytology ( / ) Resection of primary tumor ( / ) Resection of peritoneal tumor ( / ) Intraperitoneal chemotherapy ( / ) a P, category in the first English edition of the Japanese Classification of Gastric Carcinoma [1] defined in this edition were not determined by measuring the peritoneal tumor burden or by any other objective methods. When the Japanese classification of gastric carcinoma was revised in 1998 to accord with the TNM classification of The International Union Against Cancer (UICC) [6], this classification for PM was abandoned because there was no significant difference in prognosis between any two PM-positive groups (P1, P2, or P3) [3]. The degree of peritoneal metastasis in the Second Edition is simply defined as: P0, no peritoneal metastasis; P1, peritoneal metastasis; and PX, unknown. The M-category in the TNM classification includes all types of distant metastases, such as those in liver, lung, and peritoneum, while in the Second Edition, the P and H categories are independent of the M category. However, the categorization of PM in the Second Edition has become very similar to that of the M category of the TNM classification. The problem is that assessment of the tumor burden of the PM is completely omitted from both classifications; that is, the presence or absence of PM is the only determinant, regardless of the size, volume, and distribution of PM. It seems that no quantitative estimation of PM has been reported, except for Jacquet and Sugarbaker s classification [5]. We previously developed and used a classification that grouped the macroscopic features of PM into three types; tubercular, nodal, and diffuse [7]. However, there was no significant difference in survival between these three types. We, therefore, planned this study to show the importance of volumetry of PM in gastric cancer. The rationale for palliative operation for patients with PM is still controversial. Ouchi et al. [8] suggested that gastrectomy should be performed for patients with a minimal amount of PM (P1), and that resection for moderate or extensive PM (P2 or P3) had no beneficial effect on survival or quality of life. On the other hand, another author has stated that the extent of PM did not affect prognosis and that palliative gastrectomy was indicated for patients, regardless of the extent of PM, if the primary tumor was surgically resectable and without any evidence of liver metastases [9]. Furthermore, subtotal peritonectomy has been recommended for patients with PM at a few institutes [10]. But the indications for resection and the operative procedures in the surgical strategy for the treatment of PM remain to be clarified. In the present study, we provided evidence that, if the volume of the peritoneal tumors was as small as Gr I, the patient had a high probability of good prognosis and cure-oriented surgery should be carried out. It is likely that our classification will help to confirm the application and the benefits of resection of primary tumors for patients with PM. Our classification should be used for macroscopic and histological findings, and not for radiological or ultrasonographic methods. Jacquet et al. [11] demonstrated that diagnostic imaging showed only 50% accuracy for lesions from 0.5 to 5 cm in diameter, while above 5 cm the accuracy was 90%. Exploratory laparoscopy is a less invasive method to assess PM than open laparotomy, and laparoscopy matches laparotomy in capacity to diagnoste PM [12]. Our diagnostic and therapeutic strategies for PM are as follows. When preoperative laparoscopy discloses a small amount of PM such as Gr I, cure-oriented surgery, including resection of the primary tumor and partial peritonectomy (of the region bearing peritoneal tumors) is performed. But when massive PM is present, anticancer agents, such as various combinations of 5-fluorouracil, mitomycin C, cisplatin, and etoposide are administered systemically and intraperitoneally as neoadjuvant chemotherapy. If the chemotherapy is effective, laparoscopy is carried out again. If second-look laparoscopy demonstrates complete or near complete remission of PM, cytoreductive surgery is considered; if not, second-line chemotherapy is tried, using docetaxel or paclitaxel.

7 152 T. Fujimura et al.: New classification for peritoneal metastasis References 1. Japanese Research Society for Gastric Cancer. Japanese classification of gastric carcinoma. First English Ed. Tokyo: Kanehara; Japanese Research Society for Gastric Cancer. Japanese classification of gastric carcinoma. Second English Ed. Tokyo: Kanehara; Aiko T, Sasako M, General Rules Committee of the Japanese Gastric Cancer Association. The new Japanese classification of gastric carcinoma: points to be revised. Gastric Cancer 1998;1: Sugarbaker PH, Yonemura Y. Clinical pathway for the management of resectable gastric cancer with peritoneal seeding: best palliation with a ray of hope for cure. Oncology 2000;58: Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. In: Sugarbaker PH, editor. Peritoneal carcinomatosis: principles of management. Boston: Kluwer Academic; pp International Union Against Cancer. Sobin LH, Wittekind Ch TNM classification of malignant tumors. 5th Ed. Heidelberg Berlin Tokyo New York: Springer-Verlag; Fujimura T, Yonemura Y, Kawamura T, Nojima N, Satoh T, Hirono Y, et al. Cytoreductive surgery and sandwich therapy with chemohyperthermic peritoneal perfusion and intra-aortic chemotherapy for peritoneal dissemination in gastric cancer. Oncol Rep 1996;3: Ouchi K, Sugawara T, Ono H, Fujiya T, Kamiyama Y, Kakugawa Y, et al. Therapeutic significance of palliative operations for gastric cancer for survival and quality of life. J Surg Oncol 1998; 69: Kikuchi S, Arai S, Morise M, Kobayashi N, Tsukamoto H, Shimao H, et al. Gastric cancer with metastases to the distant peritoneum: a 20-year surgical experience. Hepatogastroenterology 1998;45: Sugarbaker PH. Peritonectomy procedure. Ann Surg 1995;221: Jacquet P, Jelinek JS, Steves MA, Sugarbaker PH. Evaluation of computed tomography in patients with peritoneal carcinomatosis. Cancer 1993;72: Fujimura T, Kinami S, Ninomiya I, Kitagawa H, Fushida S, Nishimura G, et al. Diagnostic laparoscopy, serum CA125, and peritoneal metastasis in gastric cancer. Endoscopy 2002;34:

Perigastric lymph node metastases in gastric cancer: comparison of different staging systems

Perigastric lymph node metastases in gastric cancer: comparison of different staging systems Gastric Cancer (1999) 2: 201 205 Original article 1999 by International and Japanese Gastric Cancer Associations Perigastric lymph node metastases in gastric cancer: comparison of different staging systems

More information

MATERIALS AND METHODS Patients

MATERIALS AND METHODS Patients Yonago Acta Medica 2017;60:174 178 Original Article Gross Appearance and Curability Are Predictive Factors of a Better Prognosis After Gastrectomy in Gastric Cancer Patients with Metastasis to the Adjacent

More information

Topics: Staging and treatment for pancreatic cancer. Staging systems for pancreatic cancer: Differences between the Japanese and UICC systems

Topics: Staging and treatment for pancreatic cancer. Staging systems for pancreatic cancer: Differences between the Japanese and UICC systems M. J Hep Kobari Bil Pancr and S. Surg Matsuno: (1998) Staging 5:121 127 system for pancreatic cancer 121 Topics: Staging and treatment for pancreatic cancer Staging systems for pancreatic cancer: Differences

More information

Lung cancer pleural invasion was recognized as a poor prognostic

Lung cancer pleural invasion was recognized as a poor prognostic Visceral pleural invasion classification in non small cell lung cancer: A proposal on the basis of outcome assessment Kimihiro Shimizu, MD a Junji Yoshida, MD a Kanji Nagai, MD a Mitsuyo Nishimura, MD

More information

Clinicopathological Characteristics and Outcome Indicators of Stage II Gastric Cancer According to the Japanese Classification of Gastric Cancer

Clinicopathological Characteristics and Outcome Indicators of Stage II Gastric Cancer According to the Japanese Classification of Gastric Cancer Clinicopathological Characteristics and Outcome Indicators of Stage II Gastric Cancer According to the Japanese Classification of Gastric Cancer HITOSHI OJIMA 1, KEN-ICHIRO ARAKI 1, TOSHIHIDE KATO 1, KAORI

More information

Evaluation of the ratio of lymph node metastasis as a prognostic factor in patients with gastric cancer

Evaluation of the ratio of lymph node metastasis as a prognostic factor in patients with gastric cancer 122 Gastric Cancer (1999) 2: 122 128 A. Takagane et al.: Ratio of lymph node metastasis in GC 1999 by International and Japanese Gastric Cancer Associations Original article Evaluation of the ratio of

More information

Xiang Hu*, Liang Cao*, Yi Yu. Introduction

Xiang Hu*, Liang Cao*, Yi Yu. Introduction Original Article Prognostic prediction in gastric cancer patients without serosal invasion: comparative study between UICC 7 th edition and JCGS 13 th edition N-classification systems Xiang Hu*, Liang

More information

Outcome after emergency surgery in patients with a free perforation caused by gastric cancer

Outcome after emergency surgery in patients with a free perforation caused by gastric cancer experimental and therapeutic medicine 1: 199-203, 2010 199 Outcome after emergency surgery in patients with a free perforation caused by gastric cancer Hironori Tsujimoto 1, Shuichi Hiraki 1, Naoko Sakamoto

More information

Department of Surgery, Kusatsu General Hospital, Yabase Kusatsu 1660, Japan 2

Department of Surgery, Kusatsu General Hospital, Yabase Kusatsu 1660, Japan 2 Gastroenterology Research and Practice Volume 2012, Article ID 836425, 5 pages doi:10.1155/2012/836425 Clinical Study Morbidity and Mortality Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal

More information

Clinicopathological and prognostic differences between mucinous gastric carcinoma and signet-ring cell carcinoma

Clinicopathological and prognostic differences between mucinous gastric carcinoma and signet-ring cell carcinoma Original Article Clinicopathological and prognostic differences between mucinous gastric carcinoma and signet-ring cell carcinoma Zhaode Bu, Zhixue Zheng, Ziyu Li, Xiaojiang Wu, Lianhai Zhang, Aiwen Wu,

More information

ORIGINAL ARTICLE. International Journal of Surgery

ORIGINAL ARTICLE. International Journal of Surgery International Journal of Surgery (2013) 11(S1), S90 S94 Contents lists available at ScienceDirect International Journal of Surgery journal homepage: www.journal-surgery.net ORIGINAL ARTICLE Lymph node

More information

Significance of the lymph nodes in the 7th station in rational dissection for metastasis of distal gastric cancer with different T categories

Significance of the lymph nodes in the 7th station in rational dissection for metastasis of distal gastric cancer with different T categories Original Article Significance of the lymph nodes in the 7th station in rational dissection for metastasis of distal gastric cancer with different T categories Wu Song, Yulong He, Shaochuan Wang, Weiling

More information

Peritoneal Involvement in Stage II Colon Cancer

Peritoneal Involvement in Stage II Colon Cancer Anatomic Pathology / PERITONEAL INVOLVEMENT IN STAGE II COLON CANCER Peritoneal Involvement in Stage II Colon Cancer A.M. Lennon, MB, MRCPI, H.E. Mulcahy, MD, MRCPI, J.M.P. Hyland, MCh, FRCS, FRCSI, C.

More information

Clinicopathologic Characteristics and Prognosis of Gastric Cancer in Young Patients

Clinicopathologic Characteristics and Prognosis of Gastric Cancer in Young Patients Yonago Acta medica 2012;55:57 61 Clinicopathologic Characteristics and Prognosis of Gastric Cancer in Young Patients Hiroaki Saito, Seigo Takaya, Yoji Fukumoto, Tomohiro Osaki, Shigeru Tatebe and Masahide

More information

Long-term Follow-up for Patients with Papillary Thyroid Carcinoma Treated as Benign Nodules

Long-term Follow-up for Patients with Papillary Thyroid Carcinoma Treated as Benign Nodules Long-term Follow-up for Patients with Papillary Thyroid Carcinoma Treated as Benign Nodules YASUHIRO ITO, TAKUYA HIGASHIYAMA, YUUKI TAKAMURA, AKIHIRO MIYA, KAORU KOBAYASHI, FUMIO MATSUZUKA, KANJI KUMA

More information

Visceral pleural involvement (VPI) of lung cancer has

Visceral pleural involvement (VPI) of lung cancer has Visceral Pleural Involvement in Nonsmall Cell Lung Cancer: Prognostic Significance Toshihiro Osaki, MD, PhD, Akira Nagashima, MD, PhD, Takashi Yoshimatsu, MD, PhD, Sosuke Yamada, MD, and Kosei Yasumoto,

More information

Pre-operative assessment of patients for cytoreduction and HIPEC

Pre-operative assessment of patients for cytoreduction and HIPEC Pre-operative assessment of patients for cytoreduction and HIPEC Washington Hospital Center Washington, DC, USA Ovarian Cancer Surgery New Strategies Bergamo, Italy May 5, 2011 Background Cytoreductive

More information

Lung cancer is a major cause of cancer deaths worldwide.

Lung cancer is a major cause of cancer deaths worldwide. ORIGINAL ARTICLE Prognostic Factors in 3315 Completely Resected Cases of Clinical Stage I Non-small Cell Lung Cancer in Japan Teruaki Koike, MD,* Ryosuke Tsuchiya, MD, Tomoyuki Goya, MD, Yasunori Sohara,

More information

Prognostic significance of peritoneal lavage cytology in gastric cancer in Singapore

Prognostic significance of peritoneal lavage cytology in gastric cancer in Singapore Gastric Cancer (2005) 8: 228 237 DOI 10.1007/s10120-005-0343-6 2005 by International and Japanese Gastric Cancer Associations Original article Prognostic significance of peritoneal lavage cytology in gastric

More information

Risk factors for lymph node metastasis in histologically poorly differentiated type early gastric cancer

Risk factors for lymph node metastasis in histologically poorly differentiated type early gastric cancer 498 Original article Risk factors for lymph node metastasis in histologically poorly differentiated type early gastric cancer Authors C. Kunisaki 1, M. Takahashi 2, Y. Nagahori 3, T. Fukushima 3, H. Makino

More information

Summary of the study protocol of the FLOT3-Study

Summary of the study protocol of the FLOT3-Study Summary of the study protocol of the FLOT3-Study EudraCT no. 2007-005143-17 Protocol Code: S396 Title A Prospective Multicenter Study With 5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) in Patients

More information

Retroperitoneal Soft Tissue Sarcomas: Prognosis and Treatment of Primary and Recurrent Disease in 117 Patients

Retroperitoneal Soft Tissue Sarcomas: Prognosis and Treatment of Primary and Recurrent Disease in 117 Patients Retroperitoneal Soft Tissue Sarcomas: Prognosis and Treatment of Primary and Recurrent Disease in 117 Patients INGO ALLDINGER 1,2, QIN YANG 3, CHRISTIAN PILARSKY 1, HANS-DETLEV SAEGER 1, WOLFRAM T. KNOEFEL

More information

Chapter 8 Adenocarcinoma

Chapter 8 Adenocarcinoma Page 80 Chapter 8 Adenocarcinoma Overview In Japan, the proportion of squamous cell carcinoma among all cervical cancers has been declining every year. In a recent survey, non-squamous cell carcinoma accounted

More information

Prognostic Role of Gastrectomy in Patients With Gastric Cancer With Positive Peritoneal Cytology

Prognostic Role of Gastrectomy in Patients With Gastric Cancer With Positive Peritoneal Cytology Int Surg 2014;99:830 834 DOI: 10.9738/INTSURG-D-14-00119.1 Prognostic Role of Gastrectomy in Patients With Gastric Cancer With Positive Peritoneal Cytology Okihide Suzuki, Minoru Fukuchi, Erito Mochiki,

More information

Risk Factors for Para-aortic Lymph Node Metastasis of Gastric Cancer from a Randomized Controlled Trial of JCOG9501

Risk Factors for Para-aortic Lymph Node Metastasis of Gastric Cancer from a Randomized Controlled Trial of JCOG9501 Risk Factors for Para-aortic Lymph Node Metastasis of Gastric Cancer from a Randomized Controlled Trial of JCOG9501 Eiji Nomura 1, Mitsuru Sasako 2, Seiichiro Yamamoto 3, Takeshi Sano 2, Toshimasa Tsujinaka

More information

Patient Presentation. 32 y.o. female complains of lower abdominal mass CEA = 433, CA125 = 201

Patient Presentation. 32 y.o. female complains of lower abdominal mass CEA = 433, CA125 = 201 Patient Presentation 32 y.o. female complains of lower abdominal mass CEA = 433, CA125 = 201 CT shows: Thickening of the right hemidiaphragm CT shows: Fluid in the right paracolic sulcus CT shows: Large

More information

Role of Metastasectomy on Overall Survival of Patients with Metastatic Gastric Cancer

Role of Metastasectomy on Overall Survival of Patients with Metastatic Gastric Cancer J Gastric Cancer 2013;13(4):226-231 http://dx.doi.org/10.5230/jgc.2013.13.4.226 Original Article Role of Metastasectomy on Overall Survival of Patients with Metastatic Gastric Cancer Seung Wook Yang, Min

More information

Abstract. Materials and methods

Abstract. Materials and methods Int J Gynecol Cancer 2006, 16, 490 495 Long-term survival in advanced ovarian carcinoma following cytoreductive surgery with standard peritonectomy procedures A.-A.K. TENTES, C.G. MIRELIS, S.K. MARKAKIDIS,

More information

Prognostic value of visceral pleura invasion in non-small cell lung cancer q

Prognostic value of visceral pleura invasion in non-small cell lung cancer q European Journal of Cardio-thoracic Surgery 23 (2003) 865 869 www.elsevier.com/locate/ejcts Prognostic value of visceral pleura invasion in non-small cell lung cancer q Jeong-Han Kang, Kil Dong Kim, Kyung

More information

Pulmonary resection for lung cancer with malignant pleural disease first detected at thoracotomy

Pulmonary resection for lung cancer with malignant pleural disease first detected at thoracotomy European Journal of Cardio-Thoracic Surgery 41 (2012) 25 30 doi:10.1016/j.ejcts.2011.04.010 ORIGINAL ARTICLE Pulmonary resection for lung cancer with malignant pleural disease first detected at thoracotomy

More information

Surgical resection improves survival in pancreatic cancer patients without vascular invasion- a population based study

Surgical resection improves survival in pancreatic cancer patients without vascular invasion- a population based study Original article Annals of Gastroenterology (2013) 26, 346-352 Surgical resection improves survival in pancreatic cancer patients without vascular invasion- a population based study Subhankar Chakraborty

More information

Clinical Study Metastasectomy of Pulmonary Metastases from Osteosarcoma: Prognostic Factors and Indication for Repeat Metastasectomy

Clinical Study Metastasectomy of Pulmonary Metastases from Osteosarcoma: Prognostic Factors and Indication for Repeat Metastasectomy Respiratory Medicine Volume 2015, Article ID 570314, 5 pages http://dx.doi.org/10.1155/2015/570314 Clinical Study Metastasectomy of Pulmonary Metastases from Osteosarcoma: Prognostic Factors and Indication

More information

Positive impact of adding No.14v lymph node to D2 dissection on survival for distal gastric cancer patients after surgery with curative intent

Positive impact of adding No.14v lymph node to D2 dissection on survival for distal gastric cancer patients after surgery with curative intent Original Article Positive impact of adding No.14v lymph node to D2 dissection on survival for distal gastric cancer patients after surgery with curative intent Yuexiang Liang 1,2 *, Liangliang Wu 1 *,

More information

The Royal Marsden. Surgery for Gastric and GE Junction Cancer: primary palliative when and where? William Allum Consultant Surgeon

The Royal Marsden. Surgery for Gastric and GE Junction Cancer: primary palliative when and where? William Allum Consultant Surgeon The Royal Marsden Surgery for Gastric and GE Junction Cancer: primary palliative when and where? William Allum Consultant Surgeon Any surgeon can cure Surgeon - dependent No surgeon can cure EMR D2 GASTRECTOMY

More information

Surgery after intraperitoneal and systemic chemotherapy for gastric cancer with peritoneal metastasis or positive peritoneal cytology findings

Surgery after intraperitoneal and systemic chemotherapy for gastric cancer with peritoneal metastasis or positive peritoneal cytology findings Gastric Cancer (2017) 20 (Suppl 1):S128 S134 DOI 10.1007/s10120-016-0684-3 ORIGINAL ARTICLE Surgery after intraperitoneal and systemic chemotherapy for gastric cancer with peritoneal metastasis or positive

More information

In 1989, Deslauriers et al. 1 described intrapulmonary metastasis

In 1989, Deslauriers et al. 1 described intrapulmonary metastasis ORIGINAL ARTICLE Prognosis of Resected Non-Small Cell Lung Cancer Patients with Intrapulmonary Metastases Kanji Nagai, MD,* Yasunori Sohara, MD, Ryosuke Tsuchiya, MD, Tomoyuki Goya, MD, and Etsuo Miyaoka,

More information

Prognostic significance of metastatic lymph node ratio: the lymph node ratio could be a prognostic indicator for patients with gastric cancer

Prognostic significance of metastatic lymph node ratio: the lymph node ratio could be a prognostic indicator for patients with gastric cancer Hou et al. World Journal of Surgical Oncology (2018) 16:198 https://doi.org/10.1186/s12957-018-1504-5 REVIEW Open Access Prognostic significance of metastatic lymph node ratio: the lymph node ratio could

More information

Revisit of Primary Malignant Neoplasms of the Trachea: Clinical Characteristics and Survival Analysis

Revisit of Primary Malignant Neoplasms of the Trachea: Clinical Characteristics and Survival Analysis Jpn J Clin Oncol 1997;27(5)305 309 Revisit of Primary Malignant Neoplasms of the Trachea: Clinical Characteristics and Survival Analysis -, -, - - 1 Chest Department and 2 Section of Thoracic Surgery,

More information

Visceral pleura invasion (VPI) was adopted as a specific

Visceral pleura invasion (VPI) was adopted as a specific ORIGINAL ARTICLE Visceral Pleura Invasion Impact on Non-small Cell Lung Cancer Patient Survival Its Implications for the Forthcoming TNM Staging Based on a Large-Scale Nation-Wide Database Junji Yoshida,

More information

Akiko Serizawa *, Kiyoaki Taniguchi, Takuji Yamada, Kunihiko Amano, Sho Kotake, Shunichi Ito and Masakazu Yamamoto

Akiko Serizawa *, Kiyoaki Taniguchi, Takuji Yamada, Kunihiko Amano, Sho Kotake, Shunichi Ito and Masakazu Yamamoto Serizawa et al. Surgical Case Reports (2018) 4:88 https://doi.org/10.1186/s40792-018-0494-4 CASE REPORT Successful conversion surgery for unresectable gastric cancer with giant paraaortic lymph node metastasis

More information

Imaging in gastric cancer

Imaging in gastric cancer Imaging in gastric cancer Gastric cancer remains a deadly disease because of late diagnosis. Adenocarcinoma represents 90% of malignant tumors. Diagnosis is based on endoscopic examination with biopsies.

More information

Rationale for the treatment. Peritoneal Surface Malignancy

Rationale for the treatment. Peritoneal Surface Malignancy Rationale for the treatment of Peritoneal Surface Malignancy K. Van der Speeten 05/10/12 A full circle :acknowledgements Rationale for the treatment of Peritoneal Surface Malignancy K. Van der Speeten

More information

Satisfactory surgical outcome of T2 gastric cancer after modified D2 lymphadenectomy

Satisfactory surgical outcome of T2 gastric cancer after modified D2 lymphadenectomy Original Article Satisfactory surgical outcome of T2 gastric cancer after modified D2 lymphadenectomy Shupeng Zhang 1, Liangliang Wu 2, Xiaona Wang 2, Xuewei Ding 2, Han Liang 2 1 Department of General

More information

Cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei

Cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei Int J Colorectal Dis (2005) 20:155 160 DOI 10.1007/s00384-004-0648-7 O R I G I N A L A R T I C L E Z. Güner U. Schmidt M. H. Dahlke H. J. Schlitt J. Klempnauer P. Piso Cytoreductive surgery and intraperitoneal

More information

A Proposed Strategy for Treatment of Superficial Carcinoma. in the Thoracic Esophagus Based on an Analysis. of Lymph Node Metastasis

A Proposed Strategy for Treatment of Superficial Carcinoma. in the Thoracic Esophagus Based on an Analysis. of Lymph Node Metastasis Kitakanto Med J 2002 ; 52 : 189-193 189 A Proposed Strategy for Treatment of Superficial Carcinoma in the Thoracic Esophagus Based on an Analysis of Lymph Node Metastasis Susumu Kawate,' Susumu Ohwada,'

More information

Regional Therapy for Management of Peritoneal Carcinomatosis from Gastrointestinal Malignancies

Regional Therapy for Management of Peritoneal Carcinomatosis from Gastrointestinal Malignancies Regional Therapy for Management of Peritoneal Carcinomatosis from Gastrointestinal Malignancies Byrne Lee, MD FACS Chief, Mixed Tumor Surgery Service City of Hope Division of Surgical Oncology September

More information

The right middle lobe is the smallest lobe in the lung, and

The right middle lobe is the smallest lobe in the lung, and ORIGINAL ARTICLE The Impact of Superior Mediastinal Lymph Node Metastases on Prognosis in Non-small Cell Lung Cancer Located in the Right Middle Lobe Yukinori Sakao, MD, PhD,* Sakae Okumura, MD,* Mun Mingyon,

More information

RESEARCH ARTICLE. Qian Liu, Jian-Jun Bi, Yan-Tao Tian, Qiang Feng, Zhao-Xu Zheng, Zheng Wang* Abstract. Introduction. Materials and Methods

RESEARCH ARTICLE. Qian Liu, Jian-Jun Bi, Yan-Tao Tian, Qiang Feng, Zhao-Xu Zheng, Zheng Wang* Abstract. Introduction. Materials and Methods RESEARCH ARTICLE Outcome after Simultaneous Resection of Gastric Primary Tumour and Synchronous Liver Metastases: Survival Analysis of a Single-center Experience in China Qian Liu, Jian-Jun Bi, Yan-Tao

More information

Regional Therapy for Management of Peritoneal Carcinomatosis from Gastrointestinal Malignancies

Regional Therapy for Management of Peritoneal Carcinomatosis from Gastrointestinal Malignancies Regional Therapy for Management of Peritoneal Carcinomatosis from Gastrointestinal Malignancies Byrne Lee, MD FACS Chief, Mixed Tumor Surgery Service City of Hope Division of Surgical Oncology September

More information

Long-term results for patients with unresectable gastric cancer who received chemotherapy in the Japan Clinical Oncology Group (JCOG) trials

Long-term results for patients with unresectable gastric cancer who received chemotherapy in the Japan Clinical Oncology Group (JCOG) trials Gastric Cancer (2000) 3: 145 150 Original article 2000 by International and Japanese Gastric Cancer Associations Long-term results for patients with unresectable gastric cancer who received chemotherapy

More information

Metastatic mechanism of spermatic cord tumor from stomach cancer

Metastatic mechanism of spermatic cord tumor from stomach cancer Int Canc Conf J (2013) 2:191 195 DOI 10.1007/s13691-013-0-9 CANCER BOARD CONFERENCE Metastatic mechanism of spermatic cord tumor from stomach cancer Masahiro Seike Yoshikazu Kanazawa Ryuji Ohashi Tadashi

More information

Surgical management and neoadjuvant chemotherapy for stage III-IV ovarian cancer

Surgical management and neoadjuvant chemotherapy for stage III-IV ovarian cancer Ovarian cancer Surgical management and neoadjuvant chemotherapy for stage III-IV ovarian cancer JM. Classe, R. Rouzier, O.Glehen, P.Meeus, L.Gladieff, JM. Bereder, F Lécuru Suitable candidates for neo-adjuvant

More information

Tumor necrosis is a strong predictor for recurrence in patients with pathological T1a renal cell carcinoma

Tumor necrosis is a strong predictor for recurrence in patients with pathological T1a renal cell carcinoma ONCOLOGY LETTERS 9: 125-130, 2015 Tumor necrosis is a strong predictor for recurrence in patients with pathological T1a renal cell carcinoma KEIICHI ITO 1, KENJI SEGUCHI 1, HIDEYUKI SHIMAZAKI 2, EIJI TAKAHASHI

More information

Characteristics of intramural metastasis in gastric cancer. Tatsuya Hashimoto Kuniyoshi Arai Yuichi Yamashita Yoshiaki Iwasaki Tsunekazu

Characteristics of intramural metastasis in gastric cancer. Tatsuya Hashimoto Kuniyoshi Arai Yuichi Yamashita Yoshiaki Iwasaki Tsunekazu ORIGINAL ARTICLE Characteristics of intramural metastasis in gastric cancer Tatsuya Hashimoto Kuniyoshi Arai Yuichi Yamashita Yoshiaki Iwasaki Tsunekazu Hishima Author for correspondence: T. Hashimoto

More information

ORIGINAL PAPER. Marginal pulmonary function is associated with poor short- and long-term outcomes in lung cancer surgery

ORIGINAL PAPER. Marginal pulmonary function is associated with poor short- and long-term outcomes in lung cancer surgery Nagoya J. Med. Sci. 79. 37 ~ 42, 2017 doi:10.18999/nagjms.79.1.37 ORIGINAL PAPER Marginal pulmonary function is associated with poor short- and long-term outcomes in lung cancer surgery Naoki Ozeki, Koji

More information

Bone Metastases in Muscle-Invasive Bladder Cancer

Bone Metastases in Muscle-Invasive Bladder Cancer Journal of the Egyptian Nat. Cancer Inst., Vol. 18, No. 3, September: 03-08, 006 AZZA N. TAHER, M.D.* and MAGDY H. KOTB, M.D.** The Departments of Radiation Oncology* and Nuclear Medicine**, National Cancer

More information

Mucinous Adenocarcinoma of the Stomach Clinicopathological

Mucinous Adenocarcinoma of the Stomach Clinicopathological THE KURUME MEDICAL JOURNAL Vo1. 43, p. 289-294, 1996 ORIGINAL ARTICLE Mucinous Adenocarcinoma of the Stomach Clinicopathological Studies KIKUO KOUFUJI, JINRYO TAKEDA, ATSUSHI TOYONAGA, ISSEI KODAMA, KEISHIRO

More information

Extent of visceral pleural invasion and the prognosis of surgically resected node-negative non-small cell lung cancer

Extent of visceral pleural invasion and the prognosis of surgically resected node-negative non-small cell lung cancer Thoracic Cancer ISSN 1759-7706 ORIGINAL ARTICLE Extent of visceral pleural invasion and the prognosis of surgically resected node-negative non-small cell lung cancer Yangki Seok 1, Ji Yun Jeong 2 & Eungbae

More information

Research Article Evaluation of Prognosis of the Patients with Peritoneal Carcinomatosis in Gastric Carcinoma

Research Article Evaluation of Prognosis of the Patients with Peritoneal Carcinomatosis in Gastric Carcinoma Cronicon OPEN ACCESS EC GASTROENTEROLOGY AND DIGESTIVE SYSTEM Research Article Evaluation of Prognosis of the Patients with Peritoneal Carcinomatosis in Gastric Carcinoma Laila Shirin 1 *, Md Mizanur Rahman

More information

Treatment outcomes and prognostic factors of gallbladder cancer patients after postoperative radiation therapy

Treatment outcomes and prognostic factors of gallbladder cancer patients after postoperative radiation therapy Korean J Hepatobiliary Pancreat Surg 2011;15:152-156 Original Article Treatment outcomes and prognostic factors of gallbladder cancer patients after postoperative radiation therapy Suzy Kim 1,#, Kyubo

More information

is time consuming and expensive. An intra-operative assessment is not going to be helpful if there is no more tissue that can be taken to improve the

is time consuming and expensive. An intra-operative assessment is not going to be helpful if there is no more tissue that can be taken to improve the My name is Barry Feig. I am a Professor of Surgical Oncology at The University of Texas MD Anderson Cancer Center in Houston, Texas. I am going to talk to you today about the role for surgery in the treatment

More information

Extended multi-organ resection for ct4 gastric carcinoma: A retrospective analysis

Extended multi-organ resection for ct4 gastric carcinoma: A retrospective analysis Original Article Extended multi-organ resection for ct4 gastric carcinoma: A retrospective analysis 1. Longbin Xiao, 2. Mingzhe Li, 3. Fengfeng Xu, Department of General Surgery I, 4. Huishao Ye, Department

More information

Review of a Personal Experience in the Management of Carcinomatosis and Sarcomatosis

Review of a Personal Experience in the Management of Carcinomatosis and Sarcomatosis Jpn J Clin Oncol 2001;31(12)573 583 Special Article Review of a Personal Experience in the Management of Carcinomatosis and Sarcomatosis Paul H. Sugarbaker Washington Cancer Institute, Washington, DC,

More information

Long-term postoperative survival of a gastric cancer patient with numerous para-aortic lymph node metastases

Long-term postoperative survival of a gastric cancer patient with numerous para-aortic lymph node metastases Gastric Cancer (1999) 2: 235 239 1999 by International and Japanese Gastric Cancer Associations Case report Long-term postoperative survival of a gastric cancer patient with numerous para-aortic lymph

More information

MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER

MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER 10 MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER Recommendations from the EAU Working Party on Muscle Invasive and Metastatic Bladder Cancer G. Jakse (chairman), F. Algaba, S. Fossa, A. Stenzl, C. Sternberg

More information

Chapter 2: Initial treatment for endometrial cancer (including histologic variant type)

Chapter 2: Initial treatment for endometrial cancer (including histologic variant type) Chapter 2: Initial treatment for endometrial cancer (including histologic variant type) CQ01 Which surgical techniques for hysterectomy are recommended for patients considered to be stage I preoperatively?

More information

Interactive Staging Bee

Interactive Staging Bee Interactive Staging Bee ROBIN BILLET, MA, CTR GA/SC REGIONAL CONFERENCE NOVEMBER 6, 2018? Clinical Staging includes any information obtained about the extent of cancer obtained before initiation of treatment

More information

After primary tumor treatment, 30% of patients with malignant

After primary tumor treatment, 30% of patients with malignant ESTS METASTASECTOMY SUPPLEMENT Alberto Oliaro, MD, Pier L. Filosso, MD, Maria C. Bruna, MD, Claudio Mossetti, MD, and Enrico Ruffini, MD Abstract: After primary tumor treatment, 30% of patients with malignant

More information

Appraisal of surgical resection of gallbladder cancer with special reference to lymph node dissection

Appraisal of surgical resection of gallbladder cancer with special reference to lymph node dissection Langenbeck s Arch Surg (2000) 385:509 514 DOI 10.1007/s004230000163 CURRENT CONCEPTS IN CLINICAL SURGERY Hiroshi Shimada Itaru Endo Yoshiro Fujii Noriyuki Kamiya Hideki Masunari Osamu Kunihiro Kuniya Tanaka

More information

Radiation Therapy for Recurrent Esophageal Cancer after Surgery: Clinical Results and Prognostic Factors

Radiation Therapy for Recurrent Esophageal Cancer after Surgery: Clinical Results and Prognostic Factors Radiation Therapy for Recurrent Esophageal Cancer after Surgery: Clinical Results and Prognostic Factors Yoshiyuki Shioyama 1, Katsumasa Nakamura 1, Saiji Ohga 1, Satoshi Nomoto 1, Tomonari Sasaki 1, Toshihiro

More information

Gastric Cancer Histopathology Reporting Proforma

Gastric Cancer Histopathology Reporting Proforma Gastric Cancer Histopathology Reporting Proforma Mandatory questions (i.e. protocol standards) are in bold (e.g. S1.01). S1.01 Identification Family name Given name(s) Date of birth Sex Male Female Intersex/indeterminate

More information

Evaluation of prognostic scoring systems for bone metastases using single center data

Evaluation of prognostic scoring systems for bone metastases using single center data MOLECULAR AND CLINICAL ONCOLOGY 3: 1361-1370, 2015 Evaluation of prognostic scoring systems for bone metastases using single center data HIROFUMI SHIMADA 1, TAKAO SETOGUCHI 2, SHUNSUKE NAKAMURA 1, MASAHIRO

More information

Key words: appendiceal carcinoma; peritonectomy; intraperitoneal chemotherapy.

Key words: appendiceal carcinoma; peritonectomy; intraperitoneal chemotherapy. EJSO 2001; 27: 286 290 doi:10.1053/ejso.2000.1095, available online at http://www.idealibrary.com on Improved prognosis following peritonectomy procedures and hyperthermic intraperitoneal chemotherapy

More information

Evidence tabel stadiering

Evidence tabel stadiering Evidence tabel stadiering Auteurs, T stage Syst Reviews Kwee, 2007 Systematic review Studies included up to aug 2006 Kelly, 2001 Systematic review Studies included from 1991-1996 steekproefgrootte) Included

More information

Research Article Prognostic Factors in Advanced Non-Small-Cell Lung Cancer Patients: Patient Characteristics and Type of Chemotherapy

Research Article Prognostic Factors in Advanced Non-Small-Cell Lung Cancer Patients: Patient Characteristics and Type of Chemotherapy SAGE-Hindawi Access to Research Lung Cancer International Volume 2011, Article ID 152125, 4 pages doi:10.4061/2011/152125 Research Article Prognostic Factors in Advanced Non-Small-Cell Lung Cancer Patients:

More information

Exercise 15: CSv2 Data Item Coding Instructions ANSWERS

Exercise 15: CSv2 Data Item Coding Instructions ANSWERS Exercise 15: CSv2 Data Item Coding Instructions ANSWERS CS Tumor Size Tumor size is the diameter of the tumor, not the depth or thickness of the tumor. Chest x-ray shows 3.5 cm mass; the pathology report

More information

Poor Prognosis of Advanced Gastric Cancer with Metastatic Suprapancreatic Lymph Nodes

Poor Prognosis of Advanced Gastric Cancer with Metastatic Suprapancreatic Lymph Nodes Ann Surg Oncol (2013) 20:2290 2295 DOI 10.1245/s10434-012-2839-8 ORIGINAL ARTICLE GASTROINTESTINAL ONCOLOGY Poor Prognosis of Advanced Gastric Cancer with Metastatic Suprapancreatic Lymph Nodes Toru Kusano,

More information

Risk Factors and Tumor Recurrence in pt1n0m0 Gastric Cancer after Surgical Treatment

Risk Factors and Tumor Recurrence in pt1n0m0 Gastric Cancer after Surgical Treatment pissn : 293-582X, eissn : 293-5641 J Gastric Cancer 216;16(4):215-22 https://doi.org/1.523/jgc.216.16.4.215 Original Article Risk Factors and Tumor Recurrence in pt1nm Gastric Cancer after Surgical Treatment

More information

Impact of infectious complications on gastric cancer recurrence

Impact of infectious complications on gastric cancer recurrence Gastric Cancer (2015) 18:368 374 DOI 10.1007/s10120-014-0361-3 ORIGINAL ARTICLE Impact of infectious complications on gastric cancer recurrence Tsutomu Hayashi Takaki Yoshikawa Toru Aoyama Shinichi Hasegawa

More information

Clinicopathologic characteristics and prognostic factors of 63 gastric cancer patients with metachronous ovarian metastasis

Clinicopathologic characteristics and prognostic factors of 63 gastric cancer patients with metachronous ovarian metastasis Cancer Biol Med 2013;10:86-91. doi: 10.7497/j.issn.2095-3941.2013.02.004 ORIGINAL ARTICLE Clinicopathologic characteristics and prognostic factors of 63 gastric cancer patients with metachronous ovarian

More information

Key words: gastric cancer, lymphovascular invasion, recurrence

Key words: gastric cancer, lymphovascular invasion, recurrence Key words: gastric cancer, lymphovascular invasion, recurrence 139 (2177) Table I Relationship between clinicopathologic factors and lymphatic invasion in 2146 patients with gastric cancer Factors P-value

More information

CT PET SCANNING for GIT Malignancies A clinician s perspective

CT PET SCANNING for GIT Malignancies A clinician s perspective CT PET SCANNING for GIT Malignancies A clinician s perspective Damon Bizos Head, Surgical Gastroenterology Charlotte Maxeke Johannesburg Academic Hospital Case presentation 54 year old with recent onset

More information

NUMERATOR: Reports that include the pt category, the pn category and the histologic grade

NUMERATOR: Reports that include the pt category, the pn category and the histologic grade Quality ID #100 (NQF 0392): Colorectal Cancer Resection Pathology Reporting: pt Category (Primary Tumor) and pn Category (Regional Lymph Nodes) with Histologic Grade National Quality Strategy Domain: Effective

More information

Multicenter study of the long-term outcomes of endoscopic submucosal dissection for early gastric cancer in patients 80 years of age or older

Multicenter study of the long-term outcomes of endoscopic submucosal dissection for early gastric cancer in patients 80 years of age or older Gastric Cancer (2012) 15:70 75 DOI 10.1007/s10120-011-0067-8 ORIGINAL ARTICLE Multicenter study of the long-term outcomes of endoscopic submucosal dissection for early gastric cancer in patients 80 years

More information

Ovarian cancer: clinical practice the Arabic perspective

Ovarian cancer: clinical practice the Arabic perspective Lead Group Log Ovarian cancer: clinical practice the Arabic perspective Experience of Hôtel-Dieu de France University Hospital (Beirut, LEBANON) in supraradical surgery for ovarian cancer David ATALLAH

More information

Reduced Lymph Node Harvest after Neoadjuvant Chemotherapy in Gastric Cancer

Reduced Lymph Node Harvest after Neoadjuvant Chemotherapy in Gastric Cancer The Journal of International Medical Research 2011; 39: 2086 2095 Reduced Lymph Node Harvest after Neoadjuvant Chemotherapy in Gastric Cancer Z-M WU 1, R-Y TENG 2, J-G SHEN 2, S-D XIE 2, C-Y XU 2,3 AND

More information

gastric cancer; lymph node dissection;

gastric cancer; lymph node dissection; Yonago Acta Medica 18;61:175 181 Original Article Therapeutic Value of Lymph Node Dissection Along the Superior Mesenteric Vein and the Posterior Surface of the Pancreatic Head in Gastric Cancer Located

More information

B Breast cancer, managing risk of lobular, in hereditary diffuse gastric cancer, 51

B Breast cancer, managing risk of lobular, in hereditary diffuse gastric cancer, 51 Index Note: Page numbers of article titles are in boldface type. A Adenocarcinoma, gastric. See also Gastric cancer. D2 nodal dissection for 57 70 Adjuvant therapy, for gastric cancer, impact of D2 dissection

More information

Subtotal versus total gastrectomy for T3 adenocarcinoma of the antrum

Subtotal versus total gastrectomy for T3 adenocarcinoma of the antrum Gastric Cancer (2003) 6: 237 242 DOI 10.1007/s10120-003-0261-4 Original article 2003 by International and Japanese Gastric Cancer Associations Subtotal versus total gastrectomy for T3 adenocarcinoma of

More information

The Predictors of Local Recurrence after Radical Cystectomy in Patients with Invasive Bladder Cancer

The Predictors of Local Recurrence after Radical Cystectomy in Patients with Invasive Bladder Cancer The Predictors of Local Recurrence after Radical Cystectomy in Patients with Invasive Bladder Cancer Hiroki Ide, Eiji Kikuchi, Akira Miyajima, Ken Nakagawa, Takashi Ohigashi, Jun Nakashima and Mototsugu

More information

COLORECTAL CARCINOMA

COLORECTAL CARCINOMA QUICK REFERENCE FOR HEALTHCARE PROVIDERS MANAGEMENT OF COLORECTAL CARCINOMA Ministry of Health Malaysia Malaysian Society of Colorectal Surgeons Malaysian Society of Gastroenterology & Hepatology Malaysian

More information

Intraoperative pleural lavage cytology after lung resection as an independent prognostic factor for staging lung cancer

Intraoperative pleural lavage cytology after lung resection as an independent prognostic factor for staging lung cancer Intraoperative pleural lavage cytology after lung resection as an independent prognostic factor for staging lung cancer Yasushi Shintani, MD, hd, a Mitsunori Ohta, MD, hd, a Teruo Iwasaki, MD, hd, a Naoki

More information

The Royal Marsden. Surgery for Gastric and GE Junction Cancer: primary palliative when and where? William Allum

The Royal Marsden. Surgery for Gastric and GE Junction Cancer: primary palliative when and where? William Allum The Royal Marsden Surgery for Gastric and GE Junction Cancer: primary palliative when and where? William Allum The Royal Marsden William Allum Conflict of Interest None Any surgeon can cure Surgeon - dependent

More information

Chapter 5 Stage III and IVa disease

Chapter 5 Stage III and IVa disease Page 55 Chapter 5 Stage III and IVa disease Overview Concurrent chemoradiotherapy (CCRT) is recommended for stage III and IVa disease. Recommended regimen for the chemotherapy portion generally include

More information

Prognostic Factors for Survival of Stage IB Upper Lobe Non-small Cell Lung Cancer Patients: A Retrospective Study in Shanghai, China

Prognostic Factors for Survival of Stage IB Upper Lobe Non-small Cell Lung Cancer Patients: A Retrospective Study in Shanghai, China www.springerlink.com Chin J Cancer Res 23(4):265 270, 2011 265 Original Article Prognostic Factors for Survival of Stage IB Upper Lobe Non-small Cell Lung Cancer Patients: A Retrospective Study in Shanghai,

More information

Gastric linitis plastica: which role for surgical resection?

Gastric linitis plastica: which role for surgical resection? Gastric Cancer (2012) 15:56 60 DOI 10.1007/s10120-011-0063-z ORIGINAL ARTICLE Gastric linitis plastica: which role for surgical resection? Corrado Pedrazzani Daniele Marrelli Fabio Pacelli Maria Di Cosmo

More information

Case Report Five-Year Survival after Surgery for Invasive Micropapillary Carcinoma of the Stomach

Case Report Five-Year Survival after Surgery for Invasive Micropapillary Carcinoma of the Stomach Case Reports in Surgery Volume 2013, Article ID 560712, 4 pages http://dx.doi.org/10.1155/2013/560712 Case Report Five-Year Survival after Surgery for Invasive Micropapillary Carcinoma of the Stomach Shigeo

More information

Heated intraperitoneal chemotherapy and gastrectomy for gastric cancer in the U.S.: the time is now

Heated intraperitoneal chemotherapy and gastrectomy for gastric cancer in the U.S.: the time is now Short Communication Heated intraperitoneal chemotherapy and gastrectomy for gastric cancer in the U.S.: the time is now Zachary J. Brown, Jonathan M. Hernandez, R. Taylor Ripley, Jeremy L. Davis Thoracic

More information

Lymph node dissection for lung cancer is both an old

Lymph node dissection for lung cancer is both an old LOBE-SPECIFIC EXTENT OF SYSTEMATIC LYMPH NODE DISSECTION FOR NON SMALL CELL LUNG CARCINOMAS ACCORDING TO A RETROSPECTIVE STUDY OF METASTASIS AND PROGNOSIS Hisao Asamura, MD Haruhiko Nakayama, MD Haruhiko

More information